中国药物警戒2024,Vol.21Issue(8) :841-846,851.DOI:10.19803/j.1672-8629.20240341

细菌内毒素检查微量凝胶法的研究

Study of a microgel method for the examination of bacterial endotoxins

张晨雪 蔡彤 陈晨 刘涛 李文龙 裴宇盛
中国药物警戒2024,Vol.21Issue(8) :841-846,851.DOI:10.19803/j.1672-8629.20240341

细菌内毒素检查微量凝胶法的研究

Study of a microgel method for the examination of bacterial endotoxins

张晨雪 1蔡彤 1陈晨 1刘涛 2李文龙 1裴宇盛1
扫码查看

作者信息

  • 1. 中国食品药品检定研究院化学药品检定所药理室,北京 102629
  • 2. 中国科学院苏州生物医学工程技术研究所,中国科学院生物医学检验技术重点实验室,江苏苏州 215163
  • 折叠

摘要

目的 通过研究微量凝胶法确定其能否满足《中华人民共和国药典》(2020 年版)(简称"《中国药典》")要求,作为现有细菌内毒素检查法的补充.方法 依据《中国药典》四部"9101 药品质量分析方法验证指导原则"规定,按照其项下"杂质测定"中"限度"项目具体要求,对微量凝胶法(5μL样品+50μL鲎试剂)进行专属性、检测限、耐用度 3项内容进行验证,并采用凝胶法和微量凝胶法对 85 批样品进行品种适用性比较研究,对 384 批样品进行一致性比对研究.结果 经方法学验证,微量凝胶法符合《中国药典》对定性方法的要求,微量凝胶法与凝胶法相比,品种适用性与一致性比对具有等效结果.结论 微量凝胶法可以作为凝胶法的补充方法在我国推广.

Abstract

Objective To determine whether the microgel method can meet the requirements of Chinese Pharmacopoeia,as a supplement to the existing bacterial endotoxin test method.Methods According to the provisions of"9101 Guidelines for the validation of pharmaceutical quality analysis methods"in Part Ⅳ of the Pharmacopoeia of the People's Republic of China(2020 edition),the microgel method(5 μL samples+50 μL limulus ambocyte lysate)was analyzed for"specificity","limit of detection"and"durability"in the item of"Determination of impurities".The gel method and microgel method were used to compare 85 batches of samples for variety applicability and 384 batches of samples for consistency comparison.Results The microgel method was methodologically validated and showed that it met the requirements of the Pharmacopoeia of the People's Republic of China for the qualitative methods,and the microgel method was equivalent to the gel method for the comparison of the applicability and consistency of the varieties.Conclusion The microgel method can be promoted as a supplementary alternative to the gel method in China.

关键词

细菌内毒素/鲎试剂/微量凝胶法/方法学验证/品种适用性/一致性评价/补充方法

Key words

bacterial endotoxin/limulus ambocyte lysate(LAL)/microgel method/methodological validation/variety suitability/consistency comparison/complementary and alternative method

引用本文复制引用

基金项目

国家重点研发计划(2023YFC2606100)

出版年

2024
中国药物警戒
国家药品监督管理局药品评价中心(国家药品不良反应监测中心)

中国药物警戒

CSTPCD
影响因子:1.105
ISSN:1672-8629
段落导航相关论文